Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

Jiangsu Aidea Pharmaceutical Group Co., Ltd.

Clinical trials sponsored by Jiangsu Aidea Pharmaceutical Group Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

  • First human test: can a new drug called ADB116 be given safely? Results expected Dec 2026 (estimated)
  • New HIV drug candidate targets resistant strains Results expected Jun 2027 (estimated)
Browse trials soon ready across all sponsors →
Trials to join now! 2 Not yet finished but already full! 1 Completed 3
Sort by
  • New HIV drug candidate targets resistant strains

    Disease control Ongoing

    This study tests a new drug called ACC017 in adults with HIV that has become resistant to standard treatments. The trial aims to see if ACC017 can lower the amount of virus in the blood to undetectable levels. Participants receive either ACC017 or a placebo for two weeks, followe…

    Phase 1/2 • Sponsor: Jiangsu Aidea Pharmaceutical Group Co., Ltd. • Aim: Disease control

    Last updated Jul 19, 2026 00:00 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse Glossary About Terms of use Contact us

This is a site from Cyber and Space